METTL3 and hepatocellular carcinoma: In terms of chemotherapy resistance, a study found that significant downregulation of METTL3 in sorafenib-resistant hepatocellular carcinoma activated autophagy-related pathways and promoted the expression of sorafenib-resistant and angiogenic genes [117].